NeOnc Technologies Holdings, Inc. (NTHI) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NTHI SEC filings page.
NeOnc Technologies Holdings, Inc. (NTHI) reported $40K in revenue for fiscal year 2025, down 51.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Tiny and shrinking revenue sits beside escalating liabilities, while development spending and cash needs remain far larger than commercial activity.
In FY2024, operating cash outflow of$4.2M was smaller than the net loss of$11.9M , so accounting losses did not translate one-for-one into cash use. That gap signals that noncash or non-operating items materially affected the reported loss, making earnings and cash movement tell different stories.
Revenue was only
FY2025 liabilities reached
Financial Health Signals
NeOnc Technologies Holdings, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
NeOnc Technologies Holdings, Inc. generated $0 in revenue in Q2 2026.
NeOnc Technologies Holdings, Inc. reported -$14.2M in net income in Q2 2026. This represents a decrease of 150.7% from the same quarter a year earlier. Against the prior quarter it is down 61.5%.
NeOnc Technologies Holdings, Inc. earned -$0.58 per diluted share (EPS) in Q2 2026. This represents a decrease of 93.3% from the same quarter a year earlier. Against the prior quarter it is down 52.6%.
Not reported for Q2 2026.
Cash & Balance Sheet
NeOnc Technologies Holdings, Inc. held $2.0M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
NeOnc Technologies Holdings, Inc. invested $2.6M in research and development in Q2 2026. This represents an increase of 291.2% from the same quarter a year earlier. Against the prior quarter it is up 106.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
NTHI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | N/A | N/A | N/A | N/A | $40K-7.0% | N/A | N/A |
| R&D Expenses | $2.6M+291.2% | $1.3M+28.9% | N/A | $715K-25.3% | $677K+71.7% | $998K+62.4% | N/A | $957K |
| SG&A Expenses | $896K-9.0% | $489K+262.3% | N/A | $903K+270.6% | $984K+239.8% | $135K-1.7% | N/A | $244K |
| Operating Income | -$14.1M-146.5% | -$7.1M+77.9% | N/A | -$6.9M-215.6% | -$5.7M-345.9% | -$31.9M-1956.2% | N/A | -$2.2M |
| Interest Expense | $234K+380.8% | $983K+218.1% | N/A | $870K | $49K-95.8% | $309K-77.7% | N/A | N/A |
| Net Income | -$14.2M-150.7% | -$8.8M+72.7% | N/A | -$8.6M-294.4% | -$5.7M-25.6% | -$32.3M-999.9% | N/A | -$2.2M |
| EPS (Basic) | -$0.58-93.3% | -$0.38+78.7% | -$0.72-453.8% | -$0.45-275.0% | -$0.30-11.1% | -$1.78-888.9% | -$0.13 | -$0.12 |
| EPS (Diluted) | -$0.58-93.3% | -$0.38+78.7% | -$0.72-453.8% | -$0.45-275.0% | -$0.30-11.1% | -$1.78-888.9% | -$0.13 | -$0.12 |
| Diluted Shares (Avg) | 25M+29.6% | 23M+28.4% | N/A | 19M+7.2% | 19M+14.4% | 18M+9.5% | N/A | 18M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EBITDA, Income Tax.
NTHI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2M+75.1% | $3.3M-60.6% | $2.8M-17.4% | $4.1M | $3.0M | $8.4M | $3.4M | N/A |
| Current Assets | $4.2M+153.4% | $2.1M-71.5% | $1.4M-36.7% | $3.0M | $1.7M | $7.4M | $2.2M | N/A |
| Cash & Equivalents | $2.0M+1478.2% | $139K-97.5% | $59K-9.5% | $1.5M+13.4% | $125K-91.8% | $5.4M+108380.5% | $65K | $1.3M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $23.8M+60.5% | $16.6M-8.3% | $20.3M+127.9% | $15.9M | $14.8M | $18.1M | $8.9M | N/A |
| Current Liabilities | $23.5M+62.4% | $16.3M-9.8% | $20.0M+124.6% | $15.6M | $14.5M | $18.1M | $8.9M | N/A |
| Non-Current Liabilities | $255K-22.1% | $274K | $291K | $309K | $327K | $0 | $0 | N/A |
| Total Equity | -$18.5M-56.8% | -$13.2M-37.5% | -$17.5M-218.0% | -$11.8M-124.3% | -$11.8M-90.3% | -$9.6M+43.1% | -$5.5M | -$5.3M |
| Retained Earnings | -$135.8M-53.3% | -$121.6M-46.6% | -$112.8M-122.8% | -$97.2M | -$88.6M | -$82.9M | -$50.6M | N/A |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
NTHI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.8M+10.3% | -$7.0M-23.7% | -$3.6M-276.3% | -$5.8M-88.2% | -$5.3M-1570.1% | -$5.7M-3976.6% | -$954K | -$3.1M |
| Stock-Based Compensation | $5.7M+60.3% | $2.7M-84.3% | N/A | $5.0M | $3.5M | $17.4M | N/A | N/A |
| Financing Cash Flow | $6.6M | $7.1M-35.9% | $2.6M+936.2% | $7.2M+149.1% | $0-100.0% | $11.0M+6487.4% | -$315K | $2.9M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
NTHI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | N/A | N/A | -79772.1% | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | -80835.3% | N/A | N/A |
| Return on Assets | -272.2%-82.1pp | -264.8%+118.1pp | N/A | -211.0% | -190.1% | -382.9% | N/A | N/A |
| Current Ratio | 0.18+0.1x | 0.13-0.3x | 0.07-0.2x | 0.19 | 0.11 | 0.41 | 0.25 | N/A |
| Asset Turnover | 0.00 | N/A | N/A | N/A | N/A | 0.00 | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$17.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| NeOnc Technologies Holdings, Inc. NTHI | FY2025 | $40K | N/A | N/A | $84.1M | — |
| Innate Pharma S.A. IPHA | FY2025 | $50.0M | N/A | N/A | $174.3M | — |
| Elicio Therapeutics, Inc. ELTX | FY2025 | N/A | -$39.6M | N/A | $50.5M | — |
| Entrada Therapeutics, Inc. TRDA | FY2025 | $25.4M | -$143.8M | N/A | $209.5M | 41/100 |
| C4 Therapeutics, Inc. CCCC | FY2025 | $35.9M | -$105.0M | N/A | $362.9M | 65/100 |
| Kyverna Therapeutics, Inc. KYTX | FY2025 | N/A | -$161.3M | N/A | $384.7M | — |
Where NeOnc Technologies Holdings, Inc. Ranks
Frequently Asked Questions
What is NeOnc Technologies Holdings, Inc.'s annual revenue?
NeOnc Technologies Holdings, Inc. (NTHI) reported $40K in total revenue for fiscal year 2025. This represents a -51.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NeOnc Technologies Holdings, Inc.'s revenue growing?
NeOnc Technologies Holdings, Inc. (NTHI) revenue declined by 51.8% year-over-year, from $83K to $40K in fiscal year 2025.
What are NeOnc Technologies Holdings, Inc.'s total assets?
NeOnc Technologies Holdings, Inc. (NTHI) had $2.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are NeOnc Technologies Holdings, Inc.'s capital expenditures?
NeOnc Technologies Holdings, Inc. (NTHI) invested $500K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does NeOnc Technologies Holdings, Inc. spend on research and development?
NeOnc Technologies Holdings, Inc. (NTHI) invested $3.6M in research and development during fiscal year 2025.
What is NeOnc Technologies Holdings, Inc.'s current ratio?
NeOnc Technologies Holdings, Inc. (NTHI) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is NeOnc Technologies Holdings, Inc.'s P/E ratio?
NeOnc Technologies Holdings, Inc. (NTHI) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $84.1M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is NeOnc Technologies Holdings, Inc.'s price-to-sales ratio?
NeOnc Technologies Holdings, Inc. (NTHI) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $40K revenue, FY2025). The market capitalization is $84.1M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is NeOnc Technologies Holdings, Inc.'s debt-to-equity ratio negative or not reported?
NeOnc Technologies Holdings, Inc. (NTHI) has negative shareholder equity of -$17.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.